Norman Levine, M.D., professor and chief of dermatology, University of Arizona, and Gerald G. Krueger, M.D., professor of dermatology, Cumming Presidential Endowed Chair, University of Utah, discuss immunomodulatory agents in the treatment of psoriasis.
New Orleans-Psoriatic patients who responded partially or not at all to initial treatment with efalizumab (Xanelim) responded more positively and without significant adverse events during a second course of treatment.
TNF-alpha inhibitors etanercept, infliximab two of four drugs signaling new era of treatment
The chief forensic toxicologist who ruled that no Accutane (isotretinoin) was present in the body of deceased suicidal teen Charles Bishop confirmed that enough blood was present in his body during tests to validate the investigation.
The drug that pleases by paralysis is no reason to party, even in the wake of FDA approval.
Silver Spring, Md. - The FDA Dermatologic and OphthalmicAdvisory Committee on May 23 strongly recommended approval of alefacept,a systemic drug for the treatment of chronic plaque psoriasis.
test
New Orleans - Although debridement has never been proven scientifically to improve wound healing outcomes, emerging concepts recognize it as an essential component of a comprehensive approach to optimizing the wound bed, Vincent Falanga, M.D., said at the annual meeting of the American Academy of Dermatology.
New Orleans - The level of UVA protection afforded by a broad-spectrum sunscreen determines its ability to protect against UV-induced immune suppression, according to a study presented by Dominique Moyal, Ph.D., at the annual meeting of the American Academy of Dermatology.
New Orleans - Photostable UV absorbers are more efficient and more reliable in a sunscreen formulation, according to Bernd Herzog, Ph.D., and Uli Osterwalder of Ciba Specialty Chemicals in Grenzach-Wyhlen, Germany.
New Orleans - Regular use of a commercially available antidandruff shampoo containing 1 percent pyrithione zinc (PTZ) does not adversely affect hair loss in men with androgenetic alopecia and may in fact slow its progression or result in improvement, according to the results of a prospective, randomized, controlled investigation.
New Orleans - Combined intralesional and topical corticosteroid treatment can be effective for reversing eyebrow hair loss in patients with alopecia totalis and alopecia universalis, Jordana S. Gilman, M.D., reported at the annual meeting of the American Academy of Dermatology.
New Orleans - Ambulatory phlebectomy is a safe and effective outpatient procedure for treating varicose and reticular veins that offers a host of advantages compared with alternative techniques, Mitchel P. Goldman, M.D., said at the annual meeting of the American Academy of Dermatology.
New Orleans - Suture materials and needle choices for clinicians can seem to be limitless, according to Margaret Terhune, M.D. Dr. Terhune presented a thorough review of the materials and methods surgeons can select for wound closure here at the annual meeting of the American Academy of Dermatology.
New Orleans - Timing is key for a successful outcome when performing dermatologic surgery in pediatric patients, and lesion size and location are the two most important variables factoring into the equation, Annette M. Wagner, M.D., said at the annual meeting of the American Academy of Dermatology.
New York - With postexcision recurrence rates of 30 percent , Mohs surgery might be the better alternative in the treatment of sebaceous gland carcinoma, according to James M. Spencer, M.D.)
New Orleans - It is time for dermatologists to incorporate a new generation of active wound treatment products, Anna Falabella M.D., said at the annual meeting of the American Academy of Dermatology.
New Orleans - Systemic contact dermatitis may present with a variety of eczematous and noneczematous cutaneous reaction patterns and may be an overlooked diagnosis unless clinicians maintain an index of suspicion that systemic exposure to a contact allergen is driving the skin eruption, Donald V. Belsito, M.D., said at the annual meeting of the American Academy of Dermatology.
New Orleans - Dermatologists need to be aware that hepatitis C virus (HCV) infection may present with cutaneous manifestations because early diagnosis and treatment are critical for reducing morbidity and mortality from progression of the underlying infectious disease, Julia R. Nunley, M.D., said at the annual meeting of the American Academy of Dermatology.
New Orleans - Even with fairly recent advances in the testing and treatment of mycosis fungoides, difficulties still remain with the diagnosis of the rare, slowly progressing cutaneous lymphoma, David P. Fivenson, M.D., said at the annual meeting of the American Academy of Dermatology.
New Orleans - Simple measures can help alleviate any burning and stinging experienced by patients undergoing 5-ALA photodynamic therapy for treatment of actinic keratoses, Joseph Fowler, Jr., M.D., said at the annual meeting of the American Academy of Dermatology.
New Orleans - Rhinophyma resection needs to be performed in a way that allows for postoperative histopathologic study, according to Luis A. Lopardo, MD, speaking here at the 60th annual meeting of the American Academy of Dermatology.
New Orleans - The experiences of an expanding series of patients indicate infliximab (Remicade) is a valuable therapy for the management of pyoderma gangrenosum (PG), Marketa Limova, M.D., said at the annual meeting of the American Academy of Dermatology.
Maui, Hawaii - Alefacept (Amevive) for treating patients with chronic plaque psoriasis provides clinical benefits that may be long-term and are associated with significant improvement in quality of life, Mark Lebwohl, M.D., said at the 26th annual Hawaii Dermatology Seminar.
Dallas - Use of centrifuged fat yields better long-term aesthetic results for lipoaugmentation of the hands than does a technique based on noncentrifuged fat,
New Orleans - Photosensitivity is an important clue to connective tissue disease, and new studies are focusing on animal models to determine the mechanisms of the link,
New Orleans - Determining the relative risk of a cutaneous drug reaction pattern is vital to determining whether the drug(s) in question can be continued currently or rechallenged in the future,
New Orleans - Oral bexarotene (Targretin) appears to be a good palliative treatment for patients with recalcitrant late-stage S?zary syndrome, but
Rouen, France - Topical corticosteroid treatment is effective for both moderate and severe bullous pemphigoid.
New Orleans - Dermatologists should treat bullous hemorrhagic cellulitis as a medical emergency, Francisco Kerdel, M.D., said, because "if you don't, the patient can lose an arm or a leg - or die."
